July 17, 2020
Mitsubishi Tanabe Pharma said on July 16 that it has grabbed regulatory approval in Indonesia for its amyotrophic lateral sclerosis (ALS) treatment Radicava (edaravone), the first green light in an ASEAN member state. The drug will be distributed by the...read more